Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Aoudjit, K. Vuori (2001)
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cellsOncogene, 20
B. Hall, J. Fortney, L. Taylor, H. Wood, Lin Wang, S. Adams, S. Davis, L. Gibson (2004)
Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells.Cancer letters, 207 2
Addolorata Coluccia, A. Vacca, M. Duñach, L. Mologni, S. Redaelli, Victor Bustos, D. Benati, L. Pinna, C. Gambacorti-Passerini (2007)
Bcr‐Abl stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylationThe EMBO Journal, 26
Tobias Löfstedt, E. Fredlund, Linda Holmquist-Mengelbier, A. Pietras, Marie Ovenberger, L. Poellinger, S. Påhlman (2007)
Hypoxia Inducible Factor-2α in CancerCell Cycle, 6
J. Radich (2001)
Philadelphia chromosome-positive acute lymphocytic leukemia.Hematology/oncology clinics of North America, 15 1
A. Jones, C. Fujiyama, C. Blanche, J. Moore, S. Fuggle, D. Cranston, R. Bicknell, A. Harris (2001)
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 5
K. Parmar, P. Mauch, J. Vergilio, R. Sackstein, J. Down (2007)
Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxiaProceedings of the National Academy of Sciences, 104
Annelie Abrahamsson, I. Geron, J. Gotlib, K. Dao, C. Barroga, I. Newton, F. Giles, J. Durocher, Remi Creusot, M. Karimi, Carol Jones, J. Zehnder, A. Keating, R. Negrin, I. Weissman, C. Jamieson (2009)
Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generationProceedings of the National Academy of Sciences, 106
T Lofstedt, E Fredlund, L Holmquist-Mengelbier (2007)
Hypoxia inducible factor-2alpha in cancerCell Cycle, 6
M. Hendrix, E. Seftor, A. Hess, Richard Seftor (2003)
Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanomaNature Reviews Cancer, 3
P. Conrad, T. Freeman, D. Beitner‐Johnson, D. Millhorn (1999)
EPAS1 trans-Activation during Hypoxia Requires p42/p44 MAPK*The Journal of Biological Chemistry, 274
Dan Jones, D. Thomas, C. Yin, S. O'brien, J. Cortes, E. Jabbour, Megan Breeden, F. Giles, Weiqiang Zhao, H. Kantarjian (2008)
Kinase domain point mutations in Philadelphia chromosome‐positive acute lymphoblastic leukemia emerge after therapy with BCR‐ABL kinase inhibitorsCancer, 113
Lin Wang, H. O’Leary, J. Fortney, L. Gibson (2007)
Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells.Blood, 110 9
Guoliang Qing, M. Simon, M. Simon (2009)
Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes.Current opinion in genetics & development, 19 1
Noemi Rudini, A. Felici, C. Giampietro, M. Lampugnani, M. Corada, Kendra Swirsding, M. Garrè, S. Liebner, M. Letarte, P. Dijke, E. Dejana (2008)
VE‐cadherin is a critical endothelial regulator of TGF‐β signallingThe EMBO Journal, 27
E. Voura, M. Sandig, C. Siu (1998)
Cell–cell interactions during transendothelial migration of tumor cellsMicroscopy Research and Technique, 43
D. Schaft, F. Hillen, P. Pauwels, D. Kirschmann, K. Castermans, M. Egbrink, M. Tran, R. Sciot, E. Hauben, P. Hogendoorn, O. Delattre, P. Maxwell, M. Hendrix, A. Griffioen (2005)
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.Cancer research, 65 24
CJ Hu, A Sataur, L Wang, H Chen, MC Simon (2007)
The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alphaMol Biol Cell, 18
Lin Wang, J. Fortney, L. Gibson (2004)
Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt.Leukemia research, 28 7
Y. Hu, Yaoyu Chen, Lory Douglas, Shaoguang Li (2009)
β-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemiaLeukemia, 23
S. Weis, J. Cui, Leo Barnes, D. Cheresh (2004)
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasisThe Journal of Cell Biology, 167
Jeremy Ben-Shoshan, Shulamit Schwartz, G. Luboshits, Sofia Maysel-Auslender, Aya Barzelay, S. Polak‐Charcon, Eldad Tzahor, I. Barshack, A. Barak, H. Levkovitch-verbin, G. Keren, J. George (2008)
Constitutive Expression of HIF‐1α and HIF‐2α in Bone Marrow Stromal Cells Differentially Promotes Their Proangiogenic PropertiesSTEM CELLS, 26
R. Pieters, W. Carroll (2008)
Biology and treatment of acute lymphoblastic leukemia.Pediatric clinics of North America, 55 1
M. Hendrix, E. Seftor, A. Hess, Richard Seftor (2003)
Molecular plasticity of human melanoma cellsOncogene, 22
M. Smith, J. Brown, C. Fisher (1998)
Epithelioid sarcoma: presence of vascular‐endothelial cadherin and lack of epithelial cadherinHistopathology, 33
E. Seftor, P. Meltzer, G. Schatteman, L. Gruman, A. Hess, D. Kirschmann, Richard Seftor, M. Hendrix (2002)
Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry.Critical reviews in oncology/hematology, 44 1
Injune Kim, Omer Yilmaz, S. Morrison (2005)
CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells.Blood, 106 3
H. Nishigaki, C. Ito, A. Manabe, E. Coustan-Smith, Y. Yanishevski, F. Behm, S. Raimondi, D. Campana (1997)
Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia.Blood, 89 10
S. Iwamoto, K. Mihara, J. Downing, C. Pui, D. Campana (2007)
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.The Journal of clinical investigation, 117 4
M. Hendrix, E. Seftor, P. Meltzer, L. Gardner, A. Hess, D. Kirschmann, G. Schatteman, Richard Seftor (2001)
Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicryProceedings of the National Academy of Sciences of the United States of America, 98
J. Burns, T. Friedmann, W. Driever, M. Burrascano, J. Yee (1993)
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proceedings of the National Academy of Sciences of the United States of America, 90 17
Shaoguang Li, Dongguang Li (2007)
Stem cell and kinase activity-independent pathway in resistance of leukaemia to BCR-ABL kinase inhibitorsJournal of Cellular and Molecular Medicine, 11
Y. Tabe, Linhua Jin, Y. Tsutsumi‐Ishii, Yuanyuan Xu, T. McQueen, W. Priebe, G. Mills, A. Ohsaka, I. Nagaoka, M. Andreeff, M. Konopleva (2007)
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.Cancer research, 67 2
C. Pui, S. Howard (2008)
Current management and challenges of malignant disease in the CNS in paediatric leukaemia.The Lancet. Oncology, 9 3
Ryan Mudry, J. Fortney, Teresa York, Brett Hall, L. Gibson (2000)
Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy.Blood, 96 5
K. Covello, J. Kehler, Hongwei Yu, J. Gordan, A. Arsham, Cheng-Jun Hu, P. Labosky, M. Simon, B. Keith (2006)
HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.Genes & development, 20 5
B. Parker, P. Argani, B. Cook, Liangfeng Han, S. Chartrand, Mindy Zhang, Saurabh Saha, A. Bardelli, Yide Jiang, Thia Martin, M. Nacht, B. Teicher, K. Klinger, S. Sukumar, S. Madden (2004)
Alterations in Vascular Gene Expression in Invasive Breast CarcinomaCancer Research, 64
L. Hazlehurst, JS Damiano, I. Buyuksal, W. Pledger, WS Dalton (2000)
Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)Oncogene, 19
MJ Hendrix, EA Seftor, AR Hess, RE Seftor (2003)
Vasculogenic mimicry and tumour-cell plasticity: lessons from melanomaNat Rev Cancer, 3
W. Carroll, D. Bhojwani, D. Min, E. Raetz, M. Relling, S. Davies, J. Downing, C. Willman, John Reed (2003)
Pediatric acute lymphoblastic leukemia.Hematology. American Society of Hematology. Education Program
Linda Holmquist-Mengelbier, E. Fredlund, Tobias Löfstedt, R. Noguera, S. Navarro, Helén Nilsson, A. Pietras, J. Vallon-Christersson, Å. Borg, K. Gradin, L. Poellinger, S. Påhlman (2006)
Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.Cancer cell, 10 5
K. Shain, D. Yarde, M. Meads, Meijuan Huang, R. Jove, L. Hazlehurst, W. Dalton (2009)
Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation.Cancer research, 69 3
S. Faderl, H. Kantarjian, D. Thomas, J. Cortes, F. Giles, S. Pierce, M. Albitar, Z. Estrov (2000)
Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic LeukemiaLeukemia & Lymphoma, 36
L. Bailey, B. Lange, S. Rheingold, N. Bunin (2008)
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.The Lancet. Oncology, 9 9
M. Labelle, H. Schnittler, D. Aust, K. Friedrich, G. Baretton, D. Vestweber, G. Breier (2008)
Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.Cancer research, 68 5
T. Vrekoussis, E. Stathopoulos, U. Giorgi, M. Kafousi, K. Pavlaki, A. Kalogeraki, E. Chrysos, G. Fiorentini, O. Zoras (2006)
Modulation of Vascular Endothelium by Imatinib: A Study on the EA.hy 926 Endothelial Cell LineJournal of Chemotherapy, 18
L. Vincent, P. Kermani, L. Young, Joseph Cheng, Fan Zhang, K. Shido, G. Lam, Heidi Bompais-Vincent, Zhen-ping Zhu, D. Hicklin, P. Bőhlen, D. Chaplin, C. May, S. Rafii (2005)
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.The Journal of clinical investigation, 115 11
D. Hoelzer (1993)
Acute lymphoblastic leukemia--progress in children, less in adults.The New England journal of medicine, 329 18
Yan Zhou, Susan Fisher, M. Janatpour, Olga Genbacev, Elisabetta Dejana, Margaret Wheelock, C. Damsky (1997)
Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?The Journal of clinical investigation, 99 9
M. Maynard, M. Ohh (2007)
The role of hypoxia-inducible factors in cancerCellular and Molecular Life Sciences, 64
Hidenobu Koga, S. Sugiyama, K. Kugiyama, Keisuke Watanabe, H. Fukushima, Tomoko Tanaka, T. Sakamoto, M. Yoshimura, H. Jinnouchi, H. Ogawa (2005)
Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.Journal of the American College of Cardiology, 45 10
S. Shih, G. Robinson, C. Perruzzi, A. Calvo, K. Desai, Jeffery Green, I. Ali, Lois Smith, D. Senger (2002)
Molecular profiling of angiogenesis markers.The American journal of pathology, 161 1
D. Cortez, G. Reuther, A. Pendergast (1997)
The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cellsOncogene, 15
Cheng-Jun Hu, Aneesa Sataur, Liyi Wang, Hongqing Chen, M. Simon (2007)
The N-Terminal Transactivation Domain Confers Target Gene Specificity of Hypoxia-inducible Factors HIF-1α and HIF-2αMolecular Biology of the Cell, 18
M. Meads, L. Hazlehurst, W. Dalton (2008)
The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug ResistanceClinical Cancer Research, 14
T. Sethi, R. Rintoul, S. Moore, A. MacKinnon, D. Salter, C. Choo, E. Chilvers, I. Dransfield, S. Donnelly, R. Strieter, C. Haslett (1999)
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivoNature Medicine, 5
A. Atfi, L. Abécassis, M. Bourgeade (2005)
Bcr–Abl activates the AKT/FoxO3 signalling pathway to restrict transforming growth factor‐β‐mediated cytostatic signalsEMBO reports, 6
A. Bras, F. Lionneton, V. Mattot, E. Lelièvre, Bertrand Caetano, Nathalie Spruyt, F. Soncin (2007)
HIF-2α specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sitesOncogene, 26
R. Raval, K. Lau, M. Tran, H. Sowter, S. Mandriota, Ji-Liang Li, C. Pugh, P. Maxwell, A. Harris, P. Ratcliffe (2005)
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell CarcinomaMolecular and Cellular Biology, 25
I. Petit, M. Karajannis, L. Vincent, L. Young, J. Butler, A. Hooper, K. Shido, H. Steller, D. Chaplin, E. Feldman, S. Rafii (2008)
The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death.Blood, 111 4
N. Akeno, Jared Robins, Mei Zhang, M. Czyzyk-Krzeska, Thomas Clemens (2002)
Induction of Vascular Endothelial Growth Factor by IGF-I in Osteoblast-Like Cells Is Mediated by the PI3K Signaling Pathway through the Hypoxia-Inducible Factor-2α.Endocrinology, 143 2
The mechanisms by which the bone marrow microenvironment regulates tumor cell survival are diverse. This study describes the novel observation that in addition to Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) cell lines, primary patient cells also express Hypoxia Inducible Factor-2α (HIF-2α) and Vascular Endothelial Cadherin (VE-cadherin), which are regulated by Abl kinase. Tumor expression of the classical endothelial protein, VE-cadherin, has been associated with aggressive phenotype and poor prognosis in other models, but has not been investigated in hematopoietic malignancies. Targeted knockdown of VE-cadherin rendered Ph+ ALL cells more susceptible to chemotherapy, even in the presence of bone marrow stromal cell (BMSC) derived survival cues. Pre-treatment of Ph+ ALL cells with ADH100191, a VE-cadherin antagonist, resulted in increased apoptosis during in vitro chemotherapy exposure. Consistent with a role for VE-cadherin in modulation of leukemia cell viability, lentiviral-mediated expression of VE-cadherin in Ph− ALL cells resulted in increased resistance to treatment-induced apoptosis. These observations suggest a novel role for VE-cadherin in modulation of chemoresistance in Ph+ ALL.
Cancer Microenvironment – Springer Journals
Published: Mar 2, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.